Redhill Biopharma - ADR Financials

$0.58

$-0.03 (-5.57%)

As on 15-Sep-2026 15:37EDT

Market cap

$4 Mln

Revenue (TTM)

$45 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	0.29	8.04	6.53	61.80	85.76	64.36
Cost of Revenue	--	3.19	3.46	33.34	49.41	36.89
Gross Profit	0.29	4.85	3.07	28.46	36.35	27.47
Operating Expenses	8.20	19.46	-9.56	71.31	117.49	91.15
Operating Profit (EBIT)	-7.91	-14.61	12.63	-42.84	-81.14	-63.68
Other Income	--	--	--	--	--	--
Profit before Tax	-8.08	-8.27	23.92	-71.67	-97.74	-76.17
Provision for Tax	--	--	0.00	-12.42	16.57	12.84
Profit after Tax (Net Income)	-0.43	-8.27	23.92	-71.67	-97.74	-76.17
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-97.74	-76.17

Liabilities ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	4.27	-4.68	2.07	-48.40	8.88	13.86
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.86	0.50	1.74	9.82	90.84	93.14
Current Liabilities	19.22	22.22	19.24	197.45	81.47	73.24
Total Liabilities	25.35	18.04	23.05	158.87	181.19	180.24

Assets ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	18.82	6.13	6.91	72.97	92.04	109.75
Current Assets	6.53	11.91	16.14	85.90	89.15	70.50
Total Assets	25.35	18.04	23.05	158.87	181.19	180.24
Total Debt*	1.07	0.36	1.17	122.69	87.81	86.90
Net Current Assets	-12.69	-10.31	-3.10	-111.55	7.68	-2.74

Cashflow ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-9.65	-9.37	-35.82	-29.19	-65.05	-48.58
Cash Flow from Investing Activities	1.69	-0.01	0.00	8.30	-8.14	-35.65
Cash from Financing Activities	7.32	8.42	21.38	11.45	73.46	84.37
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-0.24	-3.21	43.63	-462.98	-979.40	-991.84
Cash EPS ($)	-0.01	-2.97	47.27	-410.30	-797.55	-877.97
Adjusted Book Value ($)	2.37	--	3.77	--	88.93	180.52
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-5.35	-3.64	-65.35	-188.53	-651.77	-632.54
Free Cash Flow per Share ($)	-5.36	-3.64	-65.37	-189.81	-652.93	-1,332.72

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	-84.87	1,524.07	61.69	-83.83	-99.00	-92.56
ROE (%)	206.75	632.60	-103.24	362.65	-859.70	-206.25
ROA (%)	-1.98	-40.24	26.29	-42.15	-54.09	-59.90
EBIT Margin (%)	-2,818.53	-102.11	371.87	-49.09	-94.66	-99.01
Net Margin (%)	-150.00	-102.80	366.25	-115.97	-113.98	-118.36
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-0.96	0.23	-0.89	-0.28	0.33	9.23
EBIT Growth (%)	1.85	-133.82	180.05	62.63	-27.39	-52.03
Net Profit Growth (%)	94.81	-134.57	133.37	26.68	-28.32	-80.06
EPS Growth (%)	0.93	-1.07	1.09	0.53	0.01	-0.65
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	-4.33	-1.94	0.03	0.00	0.00	-0.01
Price / Book Value	0.44	-3.42	0.39	0.00	0.03	0.04
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.14	-1.19	-0.17	-4.63	-0.79	-1.05
Close Price ($)	1.03	6.21	912.50	3,507.50	64,500.00	202,000.00
High Price ($)	6.80	962.50	7,187.50	81,750.00	288,000.00	283,750.00
Low Price ($)	0.91	6.00	160.63	3,150.00	56,000.00	81,552.50
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	0.25	-0.08	0.57	-2.53	9.89	6.27
Short term debt to equity ratio	0.04	-0.08	0.35	-2.40	0.18	0.12
Current Ratio	0.34	0.54	0.84	0.44	1.09	0.96
Quick Ratio	0.34	0.37	0.61	0.38	0.91	0.87
Interest Coverage	-424.26	-149.33	66.17	-0.73	-4.90	-5.12

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	866.78	44.34	50.31	61.29	37.93	45.51
Asset Turnover	0.01	0.39	0.07	0.36	0.47	0.51
Receivable days	3,860.03	155.56	1,151.13	208.04	131.63	87.75
Inventory Days	--	460.00	812.97	141.44	78.87	41.62
Payable days	--	637.30	396.40	87.07	85.82	77.90
Cash Conversion Cycle	--	-21.74	1,567.69	262.41	124.68	51.47